Advances in Therapy

, Volume 34, Issue 8, pp 2058–2069 | Cite as

Health-Related Quality of Life in Individuals with Down Syndrome: Results from a Non-Interventional Longitudinal Multi-National Study

  • Diana RofailEmail author
  • Daniel Froggatt
  • Rafael de la Torre
  • Jamie Edgin
  • Priya Kishnani
  • Renaud Touraine
  • Sarah Whitwham
  • Lisa Squassante
  • Omar Khwaja
  • Xavier Liogier D’Ardhuy
Original Research



To date, there is little research on health-related quality of life (HRQoL) in Down syndrome (DS), and existing research is variable with regard to reported HRQoL in DS. There are also no HRQoL measures developed specifically to be used with individuals with Down syndrome.


A multi-national, longitudinal, 24-week non-interventional study was conducted in adolescents and adults with DS. HRQoL was assessed (n = 90) using the parent-report KIDSCREEN-27 questionnaire.


HRQoL domain scores were found to be similar to those in the KIDSCREEN-27 European normative group data set on the Physical Well-being, Psychological Well-being, Autonomy and Parent Relations domains. Compared with the normative data set, the adolescent participants with DS in the current study were found to have lower scores on the Social Support and Peers domain and higher scores than the normative group on the School Environment domain. The test-retest reliability of the KIDSCREEN-27 was also examined using the intraclass correlation coefficient (ICC) in a subgroup of stable participants. The KIDSCREEN-27 demonstrated poor-to-moderate test-retest reliability; however, test-retest reliability was assessed using a long time interval between assessment time points.


The findings of this study underline that further research is needed to better understand the nature of HRQoL in DS. Further research using a shorter time interval between assessment time points to examine test-retest reliability is also required.


F. Hoffmann-La Roche Ltd.


Down syndrome Health-related quality of life HRQoL KIDSCREEN-27 Longitudinal study Non-interventional study Parent-report Test-retest reliability 



Sponsorship for this study and article-processing charges was funded by F. Hoffmann-La Roche Ltd. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of this work as a whole and have given final approval to the version to be published. Hannah Staunton (an employee of Roche Products, Ltd.) provided editorial assistance during the writing of this manuscript.


Diana Rofail is an employee of Roche Products, Ltd., and holds stock in the company. At the time of the research, Daniel Froggatt was an employee of Roche Products, Ltd. Daniel Froggatt’s current affiliation is Aon Hewitt, Sydney. Lisa Squassante is an employee of F. Hoffmann-La Roche, Ltd. Xavier Liogier D’Ardhuy is an employee of F. Hoffmann-La Roche, Ltd. Omar Khwaja is an employee of F. Hoffmann-La Roche, Ltd., and holds stock in the company. Priya Kishnani was an investigator for Roche-sponsored Down syndrome clinical trials and has received honoraria from Roche Pharmaceuticals. Renaud Touraine received fees and travel support from Roche Products, Ltd., for this study. Jamie Edgin, Rafael De La Torre and Sarah Whitwham declare that they have no conflicts of interest.

Compliance with Ethics Guidelines

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2013. Ethical approval was obtained from the relevant IRBs in each country. Written consent was obtained from participants, and for those who were incapable of giving consent, written consent was obtained from their legally acceptable representative (typically their caregiver).

Data Availability

The data sets generated during and/or analyzed during the current study are not publicly available as this research was conducted as part of a larger clinical trial and these data have not been publicly shared, but are available from the corresponding author on reasonable request.


  1. 1.
    Bittles AH, Bower C, Hussain R, et al. The four ages of Down syndrome. Eur J Public Health. 2007;17(2):221–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Katz ER, Burwinkle T, Varni JW et al. Health-related quality of life. In: Bleyer AW, Barr D, editors. Cancer in adolescents and young adults (pediatric oncology). Berlin, Heidelberg: Springer; 2007. pp. 387–400.Google Scholar
  3. 3.
    World Health Organization. Constitution of the world health organization basic document. Geneva: World Health Organization; 1948.Google Scholar
  4. 4.
    Bullinger M. Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research. Restor Neurol Neurosci. 2002;20(3–4):93–101.PubMedGoogle Scholar
  5. 5.
    Taillefer M, Dupuis G, Roberge M, et al. Health-related quality of life models: systematic review of the literature. Soc Ind Res. 2003;64(2):293–323.CrossRefGoogle Scholar
  6. 6.
    WHOQOL. The world health organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. (No. 41). England; 1995.Google Scholar
  7. 7.
    Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.CrossRefPubMedGoogle Scholar
  8. 8.
    Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Med Care. 1996;34(7):702–22.CrossRefPubMedGoogle Scholar
  9. 9.
    van Gameren-Oosterom HB, Fekkes M, Buitendijk SE, et al. Development, problem behavior, and quality of life in a population based sample of eight-year-old children with Down syndrome. PLoS One. 2001;6(7):e21879.CrossRefGoogle Scholar
  10. 10.
    Vogels T, Verrips GH, Verloove-Vanhorick SP, et al. Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res. 1998;7(5):457–65.CrossRefPubMedGoogle Scholar
  11. 11.
    Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Bertoli M, Biasini G, Calignano MT, et al. Needs and challenges of daily life for people with Down syndrome residing in the city of Rome, Italy. J Intellect Disabil Res. 2011;55(8):801–20.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mok WKY, Wong WHS, Mok GTK, et al. Validation and application of health utilities index in chinese subjects with Down syndrome. Health Qual Life Outcomes. 2014;12:144.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Graves RJ. The health-related quality of life of adults with Down syndrome. University of Tenessee, The University of Tennessee Health Science Center. 2014.Google Scholar
  15. 15.
    Alderson P. Down’s syndrome: cost, quality and value of life. Soc Sci Med. 2001;53(5):627–38.CrossRefPubMedGoogle Scholar
  16. 16.
    Skotko BG, Levine SP, Goldstein R. Self-perceptions from people with Down syndrome. Am J Med Genet Part A. 2011;155:2360–9.CrossRefGoogle Scholar
  17. 17.
    Buckley F. Modelling Down syndrome. Down Syndr Res Pract. 2008;12(2):98–102.CrossRefGoogle Scholar
  18. 18.
    Brown RI. The effects of quality of life models on the development of research and practice in the field of Down syndrome. Downs Syndr Res Pract. 1998;5(1):39–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Begley A. The self-perception of pupils with Down syndrome in relation to their academic competence, physical competence and social awareness. Int J Disabil Dev Educ. 1999;46:515–29.CrossRefGoogle Scholar
  20. 20.
    Ravens-Sieberer U, Auquier P, Erhart M, et al. The KIDSCREEN-27 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Qual Life Res. 2007;16(8):1347–56.CrossRefPubMedGoogle Scholar
  21. 21.
    Stanton LR, Coetzee RH. Down’s syndrome and dementia. Adv Psychiatr Treat. 2003;10(1):50–8.CrossRefGoogle Scholar
  22. 22.
    Ravens-Sieberer U. The kidscreen questionnaires—quality of life questionnaires for children and adults. Lengerich: Pabst Science; 2006.Google Scholar
  23. 23.
    Rothman B, Opler M, Liogier D’ardhuy X, et al. A novel, disease-specific scoring method for the clinical global impression scale (CGI) in Down syndrome: Scale development and training program. Innov Clin Neurosci. 2015;12(SupplB):1–20.Google Scholar
  24. 24.
    Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry. 2007;4(7):28–37.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Guy W. Clinical global impressions. In: Guy W, editor. Early clinical drug evaluation unit (ECDEU) assessment manual for psychopharmacology. Rockville: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976. pp. 218-222.Google Scholar
  26. 26.
    Guyatt GH, Deyo RA, Charlson M, et al. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol. 1989;42(5):403–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Fayers P, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. West Sussex, England: Wiley; 2007.Google Scholar
  28. 28.
    Kline T. Psychological testing: a practical approach to design and evaluation. Canada: University of Calgary, SAGE; 2005.Google Scholar
  29. 29.
    Sacks B, Buckley SJ. What do we know about the movement abilities of children with Down syndrome? Down Syndr News Update. 2003;2(4):131–41.Google Scholar
  30. 30.
    Buckley SJ, Bird G, Sacks B. Social development for individuals with Down syndrome—an overview. Down Syndr Issues Inf. 2002. doi: 10.3104/9781903806210.Google Scholar
  31. 31.
    Buckley SJ, Sacks B. The adolescent with Down’s syndrome: Life for the teenager and for the family. Portsmouth: Portsmouth Polytechnic; 1987.Google Scholar
  32. 32.
    Buckley SJ, Sacks B. An overview of the development of teenagers with Down syndrome (11–16 years). Down Syndr Educ Int. 2002. doi: 10.3104/9781903806043.Google Scholar
  33. 33.
    Carr J. Down’s syndrome: Children growing up. Cambridge: Cambridge University Press; 1995.CrossRefGoogle Scholar
  34. 34.
    Skotko BG, Levine SP, Macklin EA, Goldstein RD. Family perspectives about Down syndrome. Am J Med Genet Part A. 2016;170(4):930–41.CrossRefGoogle Scholar
  35. 35.
    Skotko BG, Levine SP, Goldstein R. Having a son or daughter with Down syndrome: perspectives from mothers and fathers. Am J Med Genet Part A. 2011;155:2335–47.CrossRefGoogle Scholar
  36. 36.
    Arnaud C, White-Koning M, Michelsen SI, et al. Parent-reported quality of life of children with cerebral palsy in Europe. Pediatrics. 2008;121(1):54–64.CrossRefPubMedGoogle Scholar
  37. 37.
    Ravens-Sieberer U, Herdman M, Devine J, et al. The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances. Qual Life Res. 2014;23(3):791–803.CrossRefPubMedGoogle Scholar
  38. 38.
    US Department of Health and Human Services (USDHHS). Patient-reported outcome measures: Use in medical product development to support labeling claims. 2009 Accessed 7 Dec 2016.
  39. 39.
    Murphy N, Epstein A, Leonard H, Davis E, Reddihough D, Whitehouse A, Jacoby P, Bourke J, Williams K, Downs J. Qualitative analysis of parental observations on quality of life in australian children with Down syndrome. J Dev Behav Pediatr. 2017;38(2):161–8.Google Scholar
  40. 40.
    Carducci BJ. The psychology of personality: viewpoints, research, and applications. West Sussex, England: Wiley-Blackwell; 2009.Google Scholar

Copyright information

© Springer Healthcare Ltd. 2017

Authors and Affiliations

  • Diana Rofail
    • 1
    Email author
  • Daniel Froggatt
    • 1
  • Rafael de la Torre
    • 2
  • Jamie Edgin
    • 3
  • Priya Kishnani
    • 4
  • Renaud Touraine
    • 5
  • Sarah Whitwham
    • 6
  • Lisa Squassante
    • 7
  • Omar Khwaja
    • 7
  • Xavier Liogier D’Ardhuy
    • 7
  1. 1.Roche Products LimitedWelwyn Garden CityUK
  2. 2.Hospital del Mar Medical Research Institute (IMIM)BarcelonaSpain
  3. 3.University of ArizonaTusconUSA
  4. 4.Duke UniversityDurhamUSA
  5. 5.CHU-Hopital NordSaint EtienneFrance
  6. 6.Cornwall Partnership NHS Foundation TrustRedruthUK
  7. 7.Roche Innovation Center Basel, F. Hoffmann-La Roche LtdBaselSwitzerland

Personalised recommendations